IGC Pharma (IGC) Other Non Operating Income (2010 - 2025)
IGC Pharma (IGC) posted quarterly Other Non Operating Income of $1.1 million for Q3 2025, up 2406.98% year-over-year from $43000.0 in Q3 2024, and up 252.29% quarter-over-quarter from $306000.0 in Q2 2025.
IGC Pharma (IGC) Other Non Operating Income (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Other Non Operating Income for 16 consecutive years, with $1.1 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Non Operating Income rose 2406.98% year-over-year to $1.1 million; the TTM figure through Sep 2025 stood at $1.6 million (up 1548.0% YoY), while the FY2026 annual figure was $56000.0, down 82.77% from the prior year.
- Other Non Operating Income grew to $1.1 million in Q3 2025 per IGC's latest filing, from $306000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.1 million in Q3 2025 and bottomed at $4000.0 in Q3 2021.
- Historically, Other Non Operating Income has averaged $127631.6 across 5 years, with a median of $32000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 96.16% — and 2025, when it soared 2971.43%.
- IGC Pharma's Other Non Operating Income stood at $4000.0 in 2021, then soared by 625.0% to $29000.0 in 2022, then increased by 10.34% to $32000.0 in 2023, then jumped by 53.12% to $49000.0 in 2024, then soared by 2100.0% to $1.1 million in 2025.
- Business Quant data shows IGC's Other Non Operating Income at $1.1 million in Q3 2025, $306000.0 in Q2 2025, and $215000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 306,000.00 |
| Mar 31, 2025 | 215,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | 46,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 443,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2020 | 3,000.00 |